The House Veterans’ Affairs Committee has taken the extraordinary step of issuing subpoenas to the highest levels of Oracle Health leadership following a breakdown in transparency regarding the Department of Veterans Affairs’ (VA) multi-billion dollar electronic health record (EHR) modernization program. In a unanimous 19-0 vote this week, lawmakers moved to compel the testimony of Oracle Chairman and Chief Technology Officer Larry Ellison and CEO Mike Sicilia. The decision marks a significant escalation in the ongoing friction between federal oversight bodies and the technology giant, centered on a contract that has seen its projected costs nearly triple since its inception.
The move to subpoena the executives follows a contentious hearing where lawmakers from both sides of the aisle expressed outrage over a massive increase in the contract’s cost ceiling. Initially valued at approximately $10 billion when signed in 2018, recent modifications have pushed the potential total expenditure to $27 billion. This financial expansion occurred despite explicit assurances provided to Congress by Oracle leadership less than two years ago that the company would remain within the original budgetary framework. The discrepancy has led to accusations of mismanagement and a lack of accountability in what is currently one of the largest and most complex federal IT projects in United States history.
The Evolution of a Troubled Modernization Effort
The roots of the current conflict date back to May 2018, when the VA signed a direct-award contract with Cerner Corporation. The goal was to replace the VA’s aging Veterans Health Information Systems and Technology Architecture (VistA), a legacy system that has been in use for several decades. The transition to a modern, commercial off-the-shelf system was intended to create a seamless health record interface between the Department of Defense (DoD) and the VA, ensuring that service members’ medical histories followed them from active duty into veteran status.
However, the implementation was plagued by technical hurdles from the outset. Early deployments at facilities such as the Mann-Grandstaff VA Medical Center in Spokane, Washington, were met with reports of system crashes, lost prescriptions, and "unknown" pharmacy errors that posed direct risks to patient safety. In June 2022, Oracle Corporation finalized its acquisition of Cerner for $28.3 billion, inheriting the VA contract and the mounting technical challenges associated with it.
At the time of the acquisition, Oracle executives sought to reassure a skeptical Congress. During a hearing before the Senate Appropriations Committee in June 2022, Mike Sicilia, then an executive vice president and now CEO of Oracle, testified that Oracle would modernize the system without seeking additional funds from the taxpayer for the core software implementation. Sicilia stated that the company intended to "absorb" the costs of rewriting the software for the cloud, suggesting that Oracle’s superior infrastructure would eventually lead to cost savings.
Broken Promises and the $27 Billion Ceiling
The primary catalyst for the House Committee’s subpoena was the revelation that the VA had quietly modified the contract to raise the spending ceiling to $27 billion while extending the project’s timeline to 2031. This development stood in stark contrast to the testimony provided by Sicilia in 2022. Lawmakers expressed particular frustration that they were not informed of these changes through official channels; instead, the committee learned of the $17 billion increase through independent news coverage.
Representative Maxine Dexter (D-Oregon), a key figure in the push for the subpoena, emphasized that the lack of communication was as concerning as the price hike itself. "When the company responsible for a taxpayer-funded contract that could grow from $10 billion to roughly $27 billion refuses to sit before Congress and answer questions, this committee cannot fully do its job," Dexter stated. She further argued that a private, closed-door briefing would be insufficient to address the public interest, asserting that Oracle’s leadership must be held accountable in an open forum.
The committee had originally invited Oracle executives to testify voluntarily. However, the company declined the invitation, citing scheduling conflicts and timing constraints. This refusal to appear was perceived by the committee as an attempt to evade public scrutiny, prompting the unanimous vote to issue legal summons.
Operational Realities and the "Program Reset"
The financial escalation is occurring against a backdrop of limited operational success. In April 2023, the VA announced a "program reset" for the EHR rollout. Under this reset, new deployments were halted at almost all sites to focus on improving the system’s performance and reliability at the five locations where it was already live. The VA acknowledged that the "unanticipated complexity" of the project required a fundamental rethink of the deployment strategy.
Currently, the Oracle Cerner EHR system is active in only a handful of locations, including sites in Washington, Oregon, and Ohio, as well as the Captain James A. Lovell Federal Health Care Center in Illinois. This leaves more than 160 VA medical centers still operating on the legacy VistA system. The new 2031 deadline suggests that the transition, originally intended to take a decade, will now span at least 13 years, provided no further delays occur.
The "reset" period was also intended to allow the VA to renegotiate its contract with Oracle. In May 2023, the parties agreed to shift from a five-year term to a series of five one-year terms. This change was designed to give the government more leverage, allowing for more frequent performance reviews and the imposition of financial penalties if Oracle failed to meet specific uptime and reliability benchmarks. While these metrics were strengthened, they did not prevent the eventual upward adjustment of the total contract ceiling.
Technical Hurdles and Patient Safety Concerns
The enrichment of the contract cost is partly attributed to the massive technical requirements of moving the VA’s data to the Oracle Cloud Infrastructure (OCI). Oracle has argued that moving the EHR to a modern cloud environment is essential for the system’s stability and speed. However, critics point out that the costs of this migration, along with the necessary upgrades to local hospital infrastructure—such as cabling, servers, and end-user devices—have ballooned far beyond initial estimates.
Furthermore, the human cost of the system’s failures remains a central point of concern for the committee. Reports from the VA Office of Inspector General (OIG) have documented numerous instances where the EHR system’s flaws led to patient harm. These included "lost" orders for follow-up care and failures in the medication management module. Lawmakers argue that the massive increase in funding has not yet translated into a system that veterans or clinicians can fully trust.
Broader Implications for Government Contracting
The subpoena of Larry Ellison and Mike Sicilia carries implications that extend beyond the VA. It signals a shift in how Congress intends to manage large-scale technology contracts with private-sector giants. For years, "vendor lock-in"—where the government becomes so dependent on a specific provider’s software that it cannot easily switch—has been a recurring issue in federal IT. By forcing Oracle’s top brass to testify, the House Veterans’ Affairs Committee is signaling that even the most powerful tech companies are not immune to rigorous oversight when billions of taxpayer dollars are at stake.
Industry analysts suggest that the outcome of this confrontation could influence future federal contracts for cloud services and health IT. If Oracle is forced to provide detailed justifications for the cost increases, it may set a precedent for more transparent pricing models in government technology procurement. Conversely, if the company continues to resist congressional inquiries, it could face legislative efforts to further restrict its contract or redirect funding to alternative solutions.
The Path Forward: Accountability and Transparency
As of this week, it remains uncertain when Ellison and Sicilia will appear before the committee or if Oracle will attempt to challenge the subpoenas in court. The 19-0 vote, however, demonstrates a rare moment of total bipartisan alignment, suggesting that the committee will not easily back down.
For the veterans relying on the VA health system, the stakes are high. The transition to a modern EHR is vital for the future of veteran care, but the current trajectory of the project has left many questioning whether the goal is still attainable within a reasonable budget. With 160 medical centers still awaiting the new system, the VA and Oracle face a long and difficult path toward the 2031 completion date.
The upcoming testimony, should it occur, is expected to focus on three primary areas: why the cost ceiling was raised so dramatically, why the company failed to proactively disclose these increases to Congress, and what specific technical milestones Oracle must hit to ensure that no further "resets" or price hikes are necessary. As Representative Dexter noted, "Veterans deserve a health records system that works, and taxpayers deserve to know their money is being spent responsibly." The House Veterans’ Affairs Committee appears determined to ensure that both those requirements are finally met.
